Trial Profile
Anti-viral T cell responses in patients with chronic HCV infection treated with telaprevir: can therapy induce functional T cell reconstitution? [Risposte T-linfocitarie HCV-specifiche in pazienti con epatite cronica C trattati con Telaprevir: la funzione anti-virale linfocitaria può essere ripristinata dalla terapia?]
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 03 Mar 2016
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Peginterferon alfa-2a; Ribavirin
- Indications Hepatitis C
- Focus Pharmacodynamics
- 02 Mar 2016 Status changed from recruiting to discontinued, according to European Clinical Trials Database record.
- 04 Mar 2014 New trial record